| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14727b82242af25381a728ea5833da6d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 |
| filingDate |
1998-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2eb2797b6b66e5bb7e7777aeb8211997 |
| publicationDate |
2002-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MD-1920-F2 |
| titleOfInvention |
Composition and method of prophylaxis or stopping the onset of Alzheimer's disease |
| abstract |
The invention relates to medicine, in particular to neurology and psychiatry. The invention consists in the fact that the composition contains beta-sitosterol, campesterol and stigmastanol and may further include campestanol, and the method is characterized in that a therapeutically effective amount of this phytosterol composition is administered to the mammal . |
| priorityDate |
1997-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |